Big Tech takes a step forward as Verily
unveils Study Watch
Accelovance launches HERO to hone in on
early phase cancer trials
Already a subscriber?
Log in to your digital subscription.
Subscribe to CWWeekly.
PSI, INC, Chiltern take top site ratings
CROs gaining more ground in ability to support and manage investigative site relationships
Millennials accelerate seismic shift in clinical operations
New expectations set the stage for future research
Novo Nordisk, Servier, Otsuka, Teva among top sponsors
Patient-centric study design still needed
Sites wrestle with protocol design complexity
Design decisions burdening site execution and study volunteer participation
Purchase a single issue.
Subscribe to The CenterWatch Monthly.
Copyright © 1995-2017 CenterWatch.